Literature DB >> 19566655

Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.

Denis Dufrane1, Jean-François Maillart, Najima Aouassar, Rose-Marie Goebbels, Yves Guiot, Pierre Gianello.   

Abstract

BACKGROUND: Metabolic compatibility between donor and recipient species is an important matter for pig islet xenotransplantation. Glucagon is a key hormone for the function of pig islets as well as control of hypoglycemia in the recipients of the islets. Because a discrepancy exists in the composition of glucagon cells of pig and human/primate islets, the present study was designed to determine the role of native recipient glucagon cells in the treatment of diabetes by islet transplantation in a "pig-to-primate" model.
METHODS: Streptozotocin-treated (50 mg/kg) monkeys (n = 12, follow-up of 6 to 231 days) were compared with non-diabetic animals (n = 5; follow-up, 180 days). Metabolic [fasting and intravenous glucose tolerance tests (IVGTTs) for serum levels of glucose, insulin, glucagon] and morphologic (endocrine volume density and cell mass for insulin and glucagon) were compared between non-diabetic and diabetic animals. Six additional diabetic primates were given transplants of 15 000 adult pig islet equivalents without immunosuppression to monitor glucose, glucagon, insulin, and porcine C-peptide levels until 48 h after transplantation.
RESULTS: Elevated fasting blood glucose, pathologic IVGTT, destruction of 95% of beta-cell mass, and glycosylated hemoglobin (>13%) were assessed in diabetic monkeys. The serum glucagon levels and glucagon cell mass correlated significantly with diabetes time course of diabetes (R = 0.940, p = 0.005; R = 0.663, p = 0.019, respectively). A mean increase of 89% in glucagon cell mass was observed for primates suffering from diabetes >53 days. No response of glucagon secretion was observed for diabetic animals during IVGTT, because no increase of serum insulin levels followed glucose loading. Blood glucose levels dropped after pig islet xenografts in diabetic primates. This reduction was maintained by an insulin level >20 microU/ml over the period of time of xenograft function (porcine C-peptide >0.1 ng/ml). A total restoration of native primate glucagon sensitivity to insulin was found after pig islets xenotransplantation as revealed by a reduction of 80% of the glucagon level. When graft dysfunction (>24 h post-transplantation), the insulin level dropped and glucagon levels rose again (>50 pg/ml).
CONCLUSIONS: Native glucagon cells provide morphologic and functional plasticity to diabetes. Adult pig islet xenotransplantation can restore the sensitivity of primate glucagon to insulin but cannot protect the diabetic recipient against hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566655     DOI: 10.1111/j.1399-3089.2009.00530.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  5 in total

Review 1.  Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.

Authors:  Philip E Cryer
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

Review 2.  New insights into the architecture of the islet of Langerhans: a focused cross-species assessment.

Authors:  Rafael Arrojo e Drigo; Yusuf Ali; Juan Diez; Dinesh Kumar Srinivasan; Per-Olof Berggren; Bernhard O Boehm
Journal:  Diabetologia       Date:  2015-07-28       Impact factor: 10.122

3.  α-Cell Dysfunctions and Molecular Alterations in Male Insulinopenic Diabetic Mice Are Not Completely Corrected by Insulin.

Authors:  Rodolphe Dusaulcy; Sandra Handgraaf; Mounia Heddad-Masson; Florian Visentin; Christian Vesin; Franck Reimann; Fiona Gribble; Jacques Philippe; Yvan Gosmain
Journal:  Endocrinology       Date:  2015-12-22       Impact factor: 4.736

4.  Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.

Authors:  Christine Longuet; Ana M Robledo; E Danielle Dean; Chunhua Dai; Safina Ali; Ian McGuinness; Vincent de Chavez; Patricia M Vuguin; Maureen J Charron; Alvin C Powers; Daniel J Drucker
Journal:  Diabetes       Date:  2012-11-16       Impact factor: 9.461

5.  Caprine pancreatic islet xenotransplantation into diabetic immunosuppressed BALB/c mice.

Authors:  Homayoun Hani; Zeenathul N Allaudin; Mohd-Azmi Mohd-Lila; Tengku A Tengku Ibrahim; Abas M Othman
Journal:  Xenotransplantation       Date:  2014-03-20       Impact factor: 3.907

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.